药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfamethazine
Fluspirilene
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Fluspirilene.
Sulfamethazine
Flunarizine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Flunarizine.
Sulfamethazine
Cyclandelate
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Cyclandelate.
Sulfamethazine
Prenylamine
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Prenylamine.
Sulfamethazine
Nimesulide
The therapeutic efficacy of Sodium phosphate, monobasic, unspecified form can be decreased when used in combination with Nimesulide.
Sulfamethazine
Bromotheophylline
The risk or severity of adverse effects can be increased when Bromotheophylline is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Epitizide
The risk or severity of adverse effects can be increased when Epitizide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Xipamide
The risk or severity of adverse effects can be increased when Xipamide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Muzolimine
The risk or severity of adverse effects can be increased when Muzolimine is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Clopamide
The risk or severity of adverse effects can be increased when Clopamide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Fenquizone
The risk or severity of adverse effects can be increased when Fenquizone is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Clofenamide
The risk or severity of adverse effects can be increased when Clofenamide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Clorexolone
The risk or severity of adverse effects can be increased when Clorexolone is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Cyclopenthiazide
The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Mebutizide
The risk or severity of adverse effects can be increased when Mebutizide is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Mefruside
The risk or severity of adverse effects can be increased when Mefruside is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Meticrane
The risk or severity of adverse effects can be increased when Meticrane is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Cicletanine
The risk or severity of adverse effects can be increased when Cicletanine is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Spiradoline
The risk or severity of adverse effects can be increased when Spiradoline is combined with Sodium phosphate, monobasic, unspecified form.
Sulfamethazine
Rolofylline
The risk or severity of adverse effects can be increased when Rolofylline is combined with Sodium phosphate, monobasic, unspecified form.